Company intelligence / Profile preview
Lead Chemical
Osaka, Osaka, Japanlead-chemical.co.jp ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Lead Chemical pioneered transdermal absorption technology in Japan, developing the world’s first NSAID patch (Adofeed) approved for manufacture in 1988. Their products are widely used in Japan and exported globally. In 2019, they received EU approval for a new transdermal anti-inflammatory and pain relief patch. No clinical trial data is detailed publicly.
- Therapeutic areas
- ImmunologyRheumatology
- Modalities
- Small moleculeTransdermal drug delivery system (patches)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Lead Chemical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lead Chemical.